NexMed Reviews

Recommend to a friend
Approve of CEO
NexMed President, CEO, and Director Bassam B. Damaj
Bassam B. Damaj
0 Ratings

NexMed Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Headquarters San Diego, CA
Size 1 to 50 Employees
Founded Unknown
Type Company - Public (APRI)
Industry Biotech & Pharmaceuticals
Revenue $5 to $10 million (USD) per year

Apricus Biosciences (formerly NexMed) wants you to rub it in. The drug development company uses its NexACT technology to deliver drugs through the skin; it is developing topical formulations with improved absorption rates, using already-proven drug ingredients. One of the company's products is a treatment for erectile dysfunction, Vitaros, that is sold in select international markets. Another offering, Totect, works to detoxify tissue that has been accidentially exposed to chemotherapy agents. Apricus Biosciences is also working on a topical product called Femprox ... More

Work at NexMed? Share Your Experiences


Click to Rate